138 related articles for article (PubMed ID: 32035082)
1. The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro.
Giustarini G; Huppelschoten S; Barra M; Oppelt A; Wagenaar L; Weaver RJ; Bol-Schoenmakers M; Smit JJ; van de Water B; Klingmüller U; Pieters RHH
Toxicol Appl Pharmacol; 2020 Mar; 391():114915. PubMed ID: 32035082
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction.
Beggs KM; Fullerton AM; Miyakawa K; Ganey PE; Roth RA
Toxicol Sci; 2014 Jan; 137(1):91-101. PubMed ID: 24097668
[TBL] [Abstract][Full Text] [Related]
3. Trovafloxacin-induced replication stress sensitizes HepG2 cells to tumor necrosis factor-alpha-induced cytotoxicity mediated by extracellular signal-regulated kinase and ataxia telangiectasia and Rad3-related.
Beggs KM; Maiuri AR; Fullerton AM; Poulsen KL; Breier AB; Ganey PE; Roth RA
Toxicology; 2015 May; 331():35-46. PubMed ID: 25748550
[TBL] [Abstract][Full Text] [Related]
4. Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase.
Poulsen KL; Albee RP; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2014 May; 349(2):185-91. PubMed ID: 24525298
[TBL] [Abstract][Full Text] [Related]
5. Tissue influx of neutrophils and monocytes is delayed during development of trovafloxacin-induced tumor necrosis factor-dependent liver injury in mice.
Giustarini G; Kruijssen L; van Roest M; Bleumink R; Weaver RJ; Bol-Schoenmakers M; Smit J; Pieters R
J Appl Toxicol; 2018 May; 38(5):753-765. PubMed ID: 29377180
[TBL] [Abstract][Full Text] [Related]
6. Trovafloxacin enhances the inflammatory response to a Gram-negative or a Gram-positive bacterial stimulus, resulting in neutrophil-dependent liver injury in mice.
Shaw PJ; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2009 Jul; 330(1):72-8. PubMed ID: 19351866
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.
Shaw PJ; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2009 Jan; 328(1):62-8. PubMed ID: 18820134
[TBL] [Abstract][Full Text] [Related]
8. Trovafloxacin enhances lipopolysaccharide-stimulated production of tumor necrosis factor-α by macrophages: role of the DNA damage response.
Poulsen KL; Olivero-Verbel J; Beggs KM; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2014 Jul; 350(1):164-70. PubMed ID: 24817034
[TBL] [Abstract][Full Text] [Related]
9. TNFα enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy.
Ahn JH; Jegal H; Choi MS; Kim S; Park SM; Ahn J; Han HY; Cho HS; Yoon S; Oh JH
Toxicol Lett; 2021 May; 342():73-84. PubMed ID: 33609687
[TBL] [Abstract][Full Text] [Related]
10. Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity.
Shaw PJ; Beggs KM; Sparkenbaugh EM; Dugan CM; Ganey PE; Roth RA
Toxicol Sci; 2009 Oct; 111(2):288-301. PubMed ID: 19638433
[TBL] [Abstract][Full Text] [Related]
11. Trovafloxacin-Induced Liver Injury: Lack in Regulation of Inflammation by Inhibition of Nucleotide Release and Neutrophil Movement.
Giustarini G; Vrisekoop N; Kruijssen L; Wagenaar L; van Staveren S; van Roest M; Bleumink R; Bol-Schoenmakers M; Weaver RJ; Koenderman L; Smit J; Pieters R
Toxicol Sci; 2019 Feb; 167(2):385-396. PubMed ID: 30247740
[TBL] [Abstract][Full Text] [Related]
12. The role of the hemostatic system in murine liver injury induced by coexposure to lipopolysaccharide and trovafloxacin, a drug with idiosyncratic liability.
Shaw PJ; Fullerton AM; Scott MA; Ganey PE; Roth RA
Toxicol Appl Pharmacol; 2009 May; 236(3):293-300. PubMed ID: 19367693
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.
Shaw PJ; Hopfensperger MJ; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):259-66. PubMed ID: 17709330
[TBL] [Abstract][Full Text] [Related]
14. Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury.
Shaw PJ; Ditewig AC; Waring JF; Liguori MJ; Blomme EA; Ganey PE; Roth RA
Toxicol Sci; 2009 Jan; 107(1):270-80. PubMed ID: 18930950
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils.
Waring JF; Liguori MJ; Luyendyk JP; Maddox JF; Ganey PE; Stachlewitz RF; North C; Blomme EA; Roth RA
J Pharmacol Exp Ther; 2006 Mar; 316(3):1080-7. PubMed ID: 16299187
[TBL] [Abstract][Full Text] [Related]
16. Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro.
Geisler F; Algül H; Paxian S; Schmid RM
Gastroenterology; 2007 Jun; 132(7):2489-503. PubMed ID: 17570221
[TBL] [Abstract][Full Text] [Related]
17. β-arrestin 2 attenuates lipopolysaccharide-induced liver injury
Jiang MP; Xu C; Guo YW; Luo QJ; Li L; Liu HL; Jiang J; Chen HX; Wei XQ
World J Gastroenterol; 2018 Jan; 24(2):216-225. PubMed ID: 29375207
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of LPS-induced production of inflammatory cytokines by HSP70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways.
Shi Y; Tu Z; Tang D; Zhang H; Liu M; Wang K; Calderwood SK; Xiao X
Shock; 2006 Sep; 26(3):277-84. PubMed ID: 16912653
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide inhibits TNF-induced apoptosis: role of nuclear factor-kappaB activation and reactive oxygen intermediates.
Manna SK; Aggarwal BB
J Immunol; 1999 Feb; 162(3):1510-8. PubMed ID: 9973408
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages.
Kim BH; Lee KH; Chung EY; Chang YS; Lee H; Lee CK; Min KR; Kim Y
Eur J Pharmacol; 2006 Aug; 543(1-3):158-65. PubMed ID: 16797005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
